BioMimetic Therapeutics, Inc.NASDAQ
BMTI is defunct.
  • Mar. 1, 2013, 1:29 PM

    Wright Medical Group (WMGI +1.2%) says it's completed its acquisition of BioMimetic Therapeutics (BMTI). WMGI acquired BioMimetic for an upfront purchase price of approximately $190M in cash and stock plus additional milestone payments of up to approximately $190M in cash, which are payable upon receipt of FDA approval of its Augment Bone Graft and upon achieving certain revenue milestones.

    | Mar. 1, 2013, 1:29 PM
  • Nov. 19, 2012, 8:02 AM

    Orthopedics company Wright Medical (WMGI) agrees to acquire BioMimetic Therapeutics (BMTI) for up to $380M in cash and shares. Wright will pay an initial $190M, with the rest to be based on FDA approval of BioMimetic's Augment Bone Graft and revenue milestones. The total deal values BioMimetic at up to $12.97 a share vs its Friday close of $4.15. BMTI +82% premarket at $7.55. (PR)

    | Nov. 19, 2012, 8:02 AM
  • Apr. 28, 2011, 10:37 AM

    Johnson & Johnson’s (JNJ -0.9%) newfound dominance of the orthopedic device market from its $21.3B acquisition of Synthes may pressure rivals Zimmer (ZMH +3.3%) and Stryker (SYK +0.2%) to seek purchases of their own among smaller ortho companies. Potential targets: ARTC, BMTI, WMGI.

    | Apr. 28, 2011, 10:37 AM